A 19-year-old woman had stage IA endometrial carcinoma treated with medroxyprogesterone acetate and experienced a recurrence. This patient's experience illustrates the importance of a thorough history and endometrial assessment in younger patients.
Keywords: adolescent; conservative treatment; endometrial neoplasms; fertility preservation; medroxyprogesterone acetate.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.